Chemoimmunotherapy as a new Strategy in chronic lymphocytic Leukemia German CLL study

被引：0
|
作者：
Peschel, C. [1 ]
Nitschmann, S. [1 ]
机构：
[1] Tech Univ Munich, Med Klin, Klinikum Rechts Isar, D-81675 Munich, Germany
来源：
INTERNIST | 2011年 / 52卷 / 08期
关键词：
FLUDARABINE PLUS CYCLOPHOSPHAMIDE;
D O I：
10.1007/s00108-011-2897-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1011 / 1012
页数：2
相关论文
共 50 条
  • [1] Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group
    O Al-Sawaf
    S Robrecht
    J Bahlo
    A M Fink
    P Cramer
    J von Tresckow
    C Maurer
    M Bergmann
    T Seiler
    E Lange
    M Kneba
    S Stilgenbauer
    H Döhner
    M G Kiehl
    U Jäger
    C M Wendtner
    K Fischer
    V Goede
    M Hallek
    B Eichhorst
    G Hopfinger
    Leukemia, 2017, 31 : 2251 - 2253
  • [2] Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis by the German CLL study group
    Al-Sawaf, O.
    Robrecht, S.
    Bahlo, J.
    Fink, A. M.
    Cramer, P.
    von Tresckow, J.
    Maurer, C.
    Bergmann, M.
    Seiler, T.
    Lange, E.
    Kneba, M.
    Stilgenbauer, S.
    Doehner, H.
    Kiehl, M. G.
    Jaeger, U.
    Wendtner, C. M.
    Fischer, K.
    Goede, V.
    Hallek, M.
    Eichhorst, B.
    Hopfinger, G.
    LEUKEMIA, 2017, 31 (10) : 2251 - 2253
  • [3] Chemoimmunotherapy of chronic lymphocytic leukemia
    Constantine S. Tam
    Michael J. Keating
    Nature Reviews Clinical Oncology, 2010, 7 : 521 - 532
  • [4] Chemoimmunotherapy of chronic lymphocytic leukemia
    Tam, Constantine S.
    Keating, Michael J.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (09) : 521 - 532
  • [5] Chemoimmunotherapy of chronic lymphocytic leukemia
    Tam, Constantine S.
    Keating, Michael J.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (03) : 479 - 498
  • [6] Impact of gender on outcome after chemoimmunotherapy in patients with chronic lymphocytic leukemia: a meta-analysis of the German CLL Study Group (GCLLSG)
    Al-Sawaf, Othman
    Robrecht, Sandra
    Bahlo, Jasmin
    Fink, Anna-Maria
    Cramer, Paula
    Maurer, Christian
    Bergmann, Manuela
    Dreyling, Martin
    Lange, Elisabeth
    Kneba, Michael
    Stilgenbauer, Stephan
    Jaeger, Ulrich
    Wendtner, Clemens
    Fischer, Kirsten
    Goede, Valentin
    Hallek, Michael
    Eichhorst, Barbara
    Hopfinger, Georg
    Doehner, Hartmut
    Kiehl, Michael
    LEUKEMIA & LYMPHOMA, 2017, 58 : 62 - 63
  • [7] DISEASE BURDEN OF CHEMOTHERAPY AND CHEMOIMMUNOTHERAPY TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS IN CHINA
    Zhu, S.
    Tao, L.
    Wang, J.
    Du, L.
    Xiao, D.
    Zhang, Y.
    Xuan, J.
    VALUE IN HEALTH, 2018, 21 : S108 - S108
  • [8] Chronic Lymphocytic Leukemia: Chemoimmunotherapy is over? No
    Eichhorst, Barbara
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S120 - S122
  • [9] Chemoimmunotherapy for Chronic Lymphocytic Leukemia REPLY
    Goede, Valentin
    Fischer, Kirsten
    Hallek, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2348 - 2349
  • [10] New Targetable Pathways in Chronic Lymphocytic Leukemia (CLL)
    Danilov, Alexey V.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S148 - S150
12345